Management of Children With or Exposed to HIV
Summary
- Infants diagnosed with HIV infection while receiving antiretroviral prophylaxis for the prevention of mother-to-child transmission should stop prophylactic therapy and initiate fully active combination ART (Management Guidelines)[DHHS Pediatric]
- More than 20 antiretrovirals have FDA approval for use in children; more than 15 are available as liquids or chewable tablets (Table 2)
- DHHS guidelines recommend 2 NRTIs plus either nevirapine or, if weight is ≥ 2 kg, raltegravir for children younger than 14 days[DHHS Pediatric]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content